REDWOOD CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–GenapSys Inc., the company behind the world’s …
Read More »
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), …
Read More »
The U.S. Food and Drug Administration today authorized marketing of the first test to detect …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
WATERTOWN, Mass.–(BUSINESS WIRE)–FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and …
Read More »
TUEBINGEN, Germany & HOUSTON, Texas–(BUSINESS WIRE)–Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the …
Read More »
LAUSANNE, Switzerland–(BUSINESS WIRE)–Galderma today announced that The New England Journal of Medicine (NEJM) has published …
Read More »
CULVER CITY, Calif.–(BUSINESS WIRE)–NantOmics, LLC, the leader in molecular analysis, and NantHealth, Inc. (NASDAQ: NH), a next-generation, …
Read More »
SAN DIEGO, Feb. 19, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology …
Read More »
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused …
Read More »
BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the second randomized, vehicle-controlled, pivotal Phase 3 study …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on …
Read More »
CAMPBELL, Calif.–(BUSINESS WIRE)–Saama Technologies, Inc., the number one AI clinical analytics platform company, announced today that …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused …
Read More »
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that the U.S. Food and Drug Administration …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
